Improving Diversity and Inclusion in Clinical Trials

  • Describe the importance of including diverse populations in clinical trials
  • Identify strategies to improve diversity, inclusion, and equity in clinical trials
  • List barriers or perceptions that prevent or limit diversity, inclusion, and equity in clinical trials

F. Diane Barber

PhD, ANP-BC, AOCNP, FAANP, FAAN

Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program) University of Texas MD Anderson Cancer Center

F. Diane Barber has no relevant financial disclosures

Key:

Complete
Failed
Available
Locked